Telithromycin: The first ketolide antimicrobial
- 31 August 2005
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (8) , 1144-1163
- https://doi.org/10.1016/j.clinthera.2005.08.009
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Efficacy of telithromycin in community-acquired pneumonia caused by Legionella pneumophilaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: Findings from the PROTEKT US study, 2000?2001Clinical Therapeutics, 2004
- Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzaeJournal of Antimicrobial Chemotherapy, 2004
- Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycinExpert Opinion on Pharmacotherapy, 2004
- Tissue kinetics of telithromycin, the first ketolide antibacterialJournal of Antimicrobial Chemotherapy, 2004
- Telithromycin and Myasthenia GravisClinical Infectious Diseases, 2003
- Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocciJournal of Antimicrobial Chemotherapy, 2003
- Telithromycin (HMR 3647) achieves high and sustained concentrations in tonsils of patients undergoing tonsillectomyInternational Journal of Antimicrobial Agents, 2003
- Lack of Effect of Food on the Bioavailability of a New Ketolide Antibacterial, TelithromycinScandinavian Journal of Infectious Diseases, 2002
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000